LAPATINIB AND CAPECITABINE IN THE TREATMENT OF HER2-POSITIVE BREAST CANCER WITH BRAIN METASTASES

被引：1
|
作者：
Dubianski, R. [1 ,2 ]
Brewczynska, E. [3 ,4 ]
Lemanska, I. [3 ,4 ]
Szombara, E. [5 ]
Nowecki, Z. I. [6 ]
机构：
[1] MSC Mem Canc Ctr, Breast Canc Clin, Warsaw, Poland
[2] Inst Maria Sklodowska Curie, Warsaw, Poland
[3] Maria Sklodowska Curie Mem Canc Ctr, Dept Breast Canc & Reconstruct Surg, Warsaw, Poland
[4] Inst Oncol, Warsaw, Poland
[5] Marie Curie Oncol Ctr, Warsaw, Poland
[6] Maria Sklodowska Curie Mem Canc Ctr, Deptartment Gastrointestinal Canc, Warsaw, Poland
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu329.47
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
398P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine
    Metro, G.
    Foglietta, J.
    Russillo, M.
    Stocchi, L.
    Vidiri, A.
    Giannarelli, D.
    Crino, L.
    Papaldo, P.
    Mottolese, M.
    Cognetti, F.
    Fabi, A.
    Gori, S.
    ANNALS OF ONCOLOGY, 2011, 22 (03) : 625 - 630
  • [2] Brain Metastases of Her2-Positive Breast Cancer: A Case of 34 Months' Remission with Lapatinib plus Capecitabine
    Mailliez, Audrey
    Servent, Veronique
    Bonneterre, Jacques
    Le Rhun, Emilie
    CASE REPORTS IN ONCOLOGY, 2014, 7 (02): : 555 - 559
  • [3] Brain metastases in HER2-positive breast cancer: The evolving role of lapatinib
    Tomasello, Gianluca
    Bedard, Philippe L.
    de Azambuja, Evandro
    Lossignol, Dominique
    Devriendt, Daniel
    Piccart-Gebhart, Martine J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2010, 75 (02) : 110 - 121
  • [4] Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases - the UK experience
    Sutherland, S.
    Ashley, S.
    Miles, D.
    Chan, S.
    Wardley, A.
    Davidson, N.
    Bhatti, R.
    Shehata, M.
    Nouras, H.
    Camburn, T.
    Johnston, S. R. D.
    BRITISH JOURNAL OF CANCER, 2010, 102 (06) : 995 - 1002
  • [5] Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases – the UK experience
    S Sutherland
    S Ashley
    D Miles
    S Chan
    A Wardley
    N Davidson
    R Bhatti
    M Shehata
    H Nouras
    T Camburn
    S R D Johnston
    British Journal of Cancer, 2010, 102 : 995 - 1002
  • [6] Lapatinib plus capecitabine for HER2-positive advanced breast cancer
    Geyer, Charles E.
    Forster, John
    Lindquist, Deborah
    Chan, Stephen
    Romieu, C. Gilles
    Pienkowski, Tadeusz
    Jagiello-Gruszfeld, Agnieszka
    Crown, John
    Chan, Arlene
    Kaufman, Bella
    Skarlos, Dimosthenis
    Campone, Mario
    Davidson, Neville
    Berger, Mark
    Oliva, Cristina
    Rubin, Stephen D.
    Stein, Steven
    Cameron, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (26): : 2733 - 2743
  • [7] Treatment of brain metastases of HER2-positive breast cancer
    Heudel, P.
    Tredan, O.
    Cassier, P.
    Ray-Coquard, I.
    Guastalla, J. -P.
    Bachelot, T.
    ONCOLOGIE, 2012, 14 (01) : 41 - 44
  • [8] Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases
    Lin, Nancy U.
    Eierman, Wolfgang
    Greil, Richard
    Campone, Mario
    Kaufman, Bella
    Steplewski, Klaudia
    Lane, Stephen R.
    Zembryki, Denise
    Rubin, Stephen D.
    Winer, Eric P.
    JOURNAL OF NEURO-ONCOLOGY, 2011, 105 (03) : 613 - 620
  • [9] Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases
    Nancy U. Lin
    Wolfgang Eierman
    Richard Greil
    Mario Campone
    Bella Kaufman
    Klaudia Steplewski
    Stephen R. Lane
    Denise Zembryki
    Stephen D. Rubin
    Eric P. Winer
    Journal of Neuro-Oncology, 2011, 105 : 613 - 620
  • [10] Lapatinib can restore capecitabine sensitivity in HER2-positive breast cancer
    Cha, Y.
    Kim, H. P.
    Han, S. W.
    Oh, D. Y.
    Kim, J. H.
    Im, S. A.
    Bang, Y. J.
    Kim, T. Y.
    CANCER RESEARCH, 2009, 69 (02) : 249S - 250S
12345